The U.S. Food and Drug Administration (FDA) is responsible for protecting the public health by assuring the safety, efficacy, and security of human and veterinary drugs, biological products, medical devices, our nation’s food supply, cosmetics, and products that emit radiation.
The FDA is also responsible for advancing the public health by helping to speed innovations that make medicines and foods more effective, safer, and more affordable; and helping the public get the accurate, science-based information they need to use medicines and foods to improve their health.
The FDA began examining BPM in support of a strategic vision to transform its operations in response to emerging scientific, technological, and economic trends affecting its regulatory mission. This vision reflects the principles of productivity and accountability initiated back in 2002 in the E-Government Act, and carried forward by the current administration’s efforts to make sure our government is running in the most secure, open, and efficient way possible.
Appian BPM Solution
Initially, the FDA conducted a competitive review and acquisition process to select a commercial Business Process Management System (BPMS) for a pilot program. Appian was selected for the pilot. Working on the pilot increased the agency’s internal BPM competency. Based on that, the FDA expanded to four separate BPM deployments that were self-contained and specific in scope. These projects further increased the FDA’s comfort level with BPM technology and methodology. As various Centers within the FDA began to see the power of BPM – and how it could improve their core business functions – the FDA decided to make BPM available agency-wide.
The FDA formalized that decision via a five-year Blanket Purchase Agreement (BPA) making Appian BPM available across all FDA Centers. Efficiencies will be realized across the agency in better response times from IT, consistent development practices and artifacts produced from projects, and a reduced effort to manage total contractor teams. By providing standard reference architecture, development practices, tools, and examples through reference implementation, the FDA will be able to transform its IT practices into a holistic approach that better-serves the enterprise and the public.